Obstructive Sleep Apnea is a common sleep disorder that is characterized by brief interruptions to your breathing during sleep. In the US, statistics show that between 25-30% of male adults and 9 ...

Recent findings suggest that a personalized approach to recommending CPAP machines to patients with obstructive sleep apnea ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

You could say that it’s difficult to mask the challenges that people with obstructive sleep apnea face every day. But if this pill from Apnimed, Inc. eventually gets approved by the U.S. Food ...

A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA-approved medicine for treating obstructive sleep apnea.

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

“The single biggest risk factor or cause for obstructive sleep apnea is being overweight,” explains Weiner. The doctor adds, and studies show, that around 70 per cent of sleep apnea patients ...

Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure. Seminars in respiratory and critical care medicine, 10.1055/a-2591-5502.

Obstructive sleep apnea, or OSA, affects about 1 billion people globally, and 80% of people who have it are unaware and untreated, according to the American Medical Association.

How to tell if you have Obstructive Sleep Apnea, plus what to do next When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...